NC
Nexthera Capital Portfolio holdings
AUM
$120M
1-Year Est. Return
10.01%
This Fund
S&P 500
1 Year Est. Return
+10.01%
AUM
$82.4M
AUM Growth
-$69.4M
(-46%)
Holding
34
Top Buys
| 1 | +$5.56M | |
| 2 | +$2.73M | |
| 3 | +$2.68M | |
| 4 |
ACOR
Acorda Therapeutics
ACOR
|
+$2.32M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$2.01M |
Top Sells
| 1 | +$24.3M | |
| 2 | +$14.7M | |
| 3 | +$14.4M | |
| 4 |
Heron Therapeutics
HRTX
|
+$11.3M |
| 5 |
Bausch Health
BHC
|
+$11M |
Sector Composition
| 1 | Healthcare | 92.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
MediWound
MDWD
$219M
| – | – |
-14,935
|
|
||
27
Sutro Biopharma
STRO
$414M
| – | – |
-24,950
|
|
||
28
Teva Pharmaceuticals
TEVA
$36.2B
| – | – |
0
|
|
||
29
State Street SPDR S&P Biotech ETF
XBI
$8.12B
| – | – |
0
|
|
||
|
VCNX
30
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| – | – |
-81
|
|
||
|
RVLP
31
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| – | – |
-120,620
|
|
||
|
ATNX
32
DELISTED
Athenex, Inc. Common Stock
ATNX
| – | – |
-6,165
|
|
||
|
ZSAN
33
DELISTED
Zosano Pharma Corporation
ZSAN
| – | – |
-22,821
|
|
||
|
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-396,198
|
|